132 related articles for article (PubMed ID: 12095312)
21. Functional cystic fibrosis transmembrane conductance regulator tagged with an epitope of the vesicular stomatis virus glycoprotein can be addressed to the apical domain of polarized cells.
Costa de Beauregard MA; Edelman A; Chesnoy-Marchais D; Tondelier D; Lapillonne A; El Marjou F; Robine S; Louvard D
Eur J Cell Biol; 2000 Nov; 79(11):795-802. PubMed ID: 11139142
[TBL] [Abstract][Full Text] [Related]
22. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
23. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
Sermet-Gaudelus I; Déchaux M; Vallée B; Fajac A; Girodon E; Nguyen-Khoa T; Marianovski R; Hurbain I; Bresson JL; Lenoir G; Edelman A
Am J Respir Crit Care Med; 2005 May; 171(9):1026-31. PubMed ID: 15709055
[TBL] [Abstract][Full Text] [Related]
24. Nasal potential difference in congenital bilateral absence of the vas deferens.
Pradal U; Castellani C; Delmarco A; Mastella G
Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023
[TBL] [Abstract][Full Text] [Related]
25. Novel short chain fatty acids restore chloride secretion in cystic fibrosis.
Nguyen TD; Kim US; Perrine SP
Biochem Biophys Res Commun; 2006 Mar; 342(1):245-52. PubMed ID: 16472777
[TBL] [Abstract][Full Text] [Related]
26. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
[TBL] [Abstract][Full Text] [Related]
27. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.
Johnson LG; Boyles SE; Wilson J; Boucher RC
J Clin Invest; 1995 Mar; 95(3):1377-82. PubMed ID: 7533790
[TBL] [Abstract][Full Text] [Related]
28. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.
Clancy JP; Bebök Z; Ruiz F; King C; Jones J; Walker L; Greer H; Hong J; Wing L; Macaluso M; Lyrene R; Sorscher EJ; Bedwell DM
Am J Respir Crit Care Med; 2001 Jun; 163(7):1683-92. PubMed ID: 11401894
[TBL] [Abstract][Full Text] [Related]
29. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
30. Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR.
MacVinish LJ; Cope G; Ropenga A; Cuthbert AW
Br J Pharmacol; 2007 Apr; 150(8):1055-65. PubMed ID: 17339840
[TBL] [Abstract][Full Text] [Related]
31. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
Namkung W; Kim KH; Lee MG
Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
[TBL] [Abstract][Full Text] [Related]
32. Long-term azithromycin in cystic fibrosis: another possible mechanism of action?
Pradal U; Delmarco A; Morganti M; Cipolli M; Mini E; Cazzola G
J Chemother; 2005 Aug; 17(4):393-400. PubMed ID: 16167518
[TBL] [Abstract][Full Text] [Related]
33. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
[TBL] [Abstract][Full Text] [Related]
34. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
Reddy MM; Quinton PM
JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
[TBL] [Abstract][Full Text] [Related]
35. Annexin A5 increases the cell surface expression and the chloride channel function of the DeltaF508-cystic fibrosis transmembrane regulator.
Le Drévo MA; Benz N; Kerbiriou M; Giroux-Metges MA; Pennec JP; Trouvé P; Férec C
Biochim Biophys Acta; 2008 Oct; 1782(10):605-14. PubMed ID: 18773956
[TBL] [Abstract][Full Text] [Related]
36. A phase I trial of intranasal Moli1901 for cystic fibrosis.
Zeitlin PL; Boyle MP; Guggino WB; Molina L
Chest; 2004 Jan; 125(1):143-9. PubMed ID: 14718433
[TBL] [Abstract][Full Text] [Related]
37. Focus on "Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR".
Bradbury NA
Am J Physiol Cell Physiol; 2000 Feb; 278(2):C257-8. PubMed ID: 10666019
[No Abstract] [Full Text] [Related]
38. Gentamicin and CFTR.
Kida Y
N Engl J Med; 2003 Dec; 349(26):2570. PubMed ID: 14695425
[No Abstract] [Full Text] [Related]
39. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function.
Rubenstein RC; Zeitlin PL
Am J Respir Crit Care Med; 1998 Feb; 157(2):484-90. PubMed ID: 9476862
[TBL] [Abstract][Full Text] [Related]
40. A Proximity Complementation Assay to Identify Small Molecules That Enhance the Traffic of ABCA4 Misfolding Variants.
Piccolo D; Zarouchlioti C; Bellingham J; Guarascio R; Ziaka K; Molday RS; Cheetham ME
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
